There's no shortage of science fiction movies featuring an engineered bacteria or virus that breaks out of a secret government lab and wreaks untold havoc on the unsuspecting public, sometimes causing worldwide devastation. That couldn't really happen, of course. Right? Well, there are some eerie similarities between those plots and antibiotic resistance. Switch "secret government labs" with hospitals, realize that our carelessness with antibiotics has indeed engineered dozens of species and hundreds of strains of microbes, and forget the thing about blood-hungry zombies. In about five to 10 years, things could really deteriorate into a global crisis. Seriously.
Every year, tens of thousands of people die from infections caused by superbugs acquired in hospitals. Here's the scary part: This isn't occurring in some Third World country. This is happening in the United States, within miles of where you live. Similar statistics are reported for developed nations in Europe and Asia. The government has become increasingly worried about the prevalence of superbugs and the lack of drugs in development to fight them. In the following video, Fool contributor Maxx Chatsko explains a recent, perhaps last-ditch effort for a public-private partnership aiming to find a solution to the problem.
Contrary to a 10-day regimen of antibiotic treatment, the best investing approach is to choose great companies and stick with them for the long term. The Motley Fool's free report "3 Stocks That Will Help You Retire Rich" names stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.